Siddharth M. Patel MD, MPH , David D. Berg MD, MPH , Erin A. Bohula MD, DPhil , Vivian M. Baird-Zars MPH , Jeong-Gun Park PhD , Christopher F. Barnett MD, MPH , Lori B. Daniels MD, MAS , Christopher B. Fordyce MD, MHS, MSc , Shahab Ghafghazi MD , Michael J. Goldfarb MD, MSc , Kari Gorder MD , Younghoon Kwon MD , Evan Leibner MD, PhD , Venu Menon MD , Brian J. Potter MD, MSc , Rajnish Prasad MD , Michael A. Solomon MD, MBA , Jeffrey J. Teuteberg MD , Andrea D. Thompson MD, PhD , Sammy Zakaria MD, MPH , David A. Morrow MD, MPH
{"title":"Continuum of Preshock to Classic Cardiogenic Shock in the Critical Care Cardiology Trials Network Registry","authors":"Siddharth M. Patel MD, MPH , David D. Berg MD, MPH , Erin A. Bohula MD, DPhil , Vivian M. Baird-Zars MPH , Jeong-Gun Park PhD , Christopher F. Barnett MD, MPH , Lori B. Daniels MD, MAS , Christopher B. Fordyce MD, MHS, MSc , Shahab Ghafghazi MD , Michael J. Goldfarb MD, MSc , Kari Gorder MD , Younghoon Kwon MD , Evan Leibner MD, PhD , Venu Menon MD , Brian J. Potter MD, MSc , Rajnish Prasad MD , Michael A. Solomon MD, MBA , Jeffrey J. Teuteberg MD , Andrea D. Thompson MD, PhD , Sammy Zakaria MD, MPH , David A. Morrow MD, MPH","doi":"10.1016/j.jchf.2024.06.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The prognostic implications of phenotypes along the preshock to cardiogenic shock (CS) continuum remain uncertain.</p></div><div><h3>Objectives</h3><p>This study sought to better characterize pre- or early shock and normotensive CS phenotypes and examine outcomes compared to those with conventional CS.</p></div><div><h3>Methods</h3><p>The CCCTN (Critical Care Cardiology Trials Network) is a registry of contemporary cardiac intensive care units. Consecutive admissions (N = 28,703 across 47 sites) meeting specific criteria based on hemodynamic variables, perfusion parameters, and investigator-reported CS were classified into 1 of 4 groups or none: isolated low cardiac output (CO), heart failure with isolated hypotension, normotensive CS, or SCAI (Society of Cardiovascular Angiography and Intervention) stage C CS. Outcomes of interest were in-hospital mortality and incidence of subsequent hypoperfusion among pre- and early shock states.</p></div><div><h3>Results</h3><p>A total of 2,498 admissions were assigned to the 4 groups with the following distribution: 4.8% isolated low CO, 4.4% isolated hypotension, 12.1% normotensive CS, and 78.7% SCAI stage C CS. Overall in-hospital mortality was 21.3% (95% CI: 19.7%-23.0%), with a gradient across phenotypes (isolated low CO 3.6% [95% CI: 1.0%-9.0%]; isolated hypotension 11.0% [95% CI: 6.9%-16.6%]; normotensive CS 17.0% [95% CI 13.0%-21.8%]; SCAI stage C CS 24.0% [95% CI: 22.1%-26.0%]; global <em>P <</em> 0.001). Among those with an isolated low CO and isolated hypotension on admission, 47 (42.3%) and 56 (30.9%) subsequently developed hypoperfusion.</p></div><div><h3>Conclusions</h3><p>In a large contemporary registry of cardiac critical illness, there exists a gradient of mortality for phenotypes along the preshock to CS continuum with risk for subsequent worsening of preshock states. These data may inform refinement of CS definitions and severity staging.</p></div>","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"12 9","pages":"Pages 1625-1635"},"PeriodicalIF":10.3000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Heart failure","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213177924005092","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The prognostic implications of phenotypes along the preshock to cardiogenic shock (CS) continuum remain uncertain.
Objectives
This study sought to better characterize pre- or early shock and normotensive CS phenotypes and examine outcomes compared to those with conventional CS.
Methods
The CCCTN (Critical Care Cardiology Trials Network) is a registry of contemporary cardiac intensive care units. Consecutive admissions (N = 28,703 across 47 sites) meeting specific criteria based on hemodynamic variables, perfusion parameters, and investigator-reported CS were classified into 1 of 4 groups or none: isolated low cardiac output (CO), heart failure with isolated hypotension, normotensive CS, or SCAI (Society of Cardiovascular Angiography and Intervention) stage C CS. Outcomes of interest were in-hospital mortality and incidence of subsequent hypoperfusion among pre- and early shock states.
Results
A total of 2,498 admissions were assigned to the 4 groups with the following distribution: 4.8% isolated low CO, 4.4% isolated hypotension, 12.1% normotensive CS, and 78.7% SCAI stage C CS. Overall in-hospital mortality was 21.3% (95% CI: 19.7%-23.0%), with a gradient across phenotypes (isolated low CO 3.6% [95% CI: 1.0%-9.0%]; isolated hypotension 11.0% [95% CI: 6.9%-16.6%]; normotensive CS 17.0% [95% CI 13.0%-21.8%]; SCAI stage C CS 24.0% [95% CI: 22.1%-26.0%]; global P < 0.001). Among those with an isolated low CO and isolated hypotension on admission, 47 (42.3%) and 56 (30.9%) subsequently developed hypoperfusion.
Conclusions
In a large contemporary registry of cardiac critical illness, there exists a gradient of mortality for phenotypes along the preshock to CS continuum with risk for subsequent worsening of preshock states. These data may inform refinement of CS definitions and severity staging.
期刊介绍:
JACC: Heart Failure publishes crucial findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal is to enhance understanding through timely scientific communication on disease, clinical trials, outcomes, and therapeutic advances. The Journal fosters interdisciplinary connections with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery related to heart failure. It also covers articles on pharmacogenetics, biomarkers, and metabolomics.